ALXO - CIK 0001810182
The table below shows ALX ONCOLOGY HOLDINGS INC's balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $32.28M | $23.44M | $19.30M | $20.61M | $16.10M | $15.53M |
| Short-term investments | $108.04M | $37.18M | $60.01M | $77.22M | $132.47M | $141.19M |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $145.56M |
| $66.52M |
| $85.26M |
| $102.53M |
| $155.90M |
| $168.71M |
| Property, plant & equipment | $1.05M | $1.35M | $1.50M | $2.70M | $3.11M | $3.32M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $178.33M | $82.72M | $95.32M | $120.90M | $185.72M | $214.62M |
| Accounts payable | $3.85M | $6.58M | $4.90M | $3.94M | $7.89M | $8.15M |
| Total current liabilities | $20.18M | $27.72M | $18.85M | $18.74M | $32.34M | $38.45M |
| Long-term debt | $3.29M | $5.76M | $7.00M | $8.23M | $9.84M | $9.77M |
| Total liabilities | $26.98M | $37.92M | $30.91M | $32.60M | $48.91M | $55.30M |
| Retained earnings | -$740.74M | -$699.97M | -$677.83M | -$651.88M | -$591.96M | -$561.25M |
| Total equity | $151.35M | $44.80M | $64.42M | $88.30M | $136.81M | $159.32M |